Gwo Xi Stem Cell Applied Technology Co. , Ltd
Gwo Xi Stem Cell Applied Technology Co. , Ltd develops stem cell technology for patients with unmet medical needs. Its products under development include GXHPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of liver cirrhosis; and GXNPC1, an autologous adipose-derived stem cell therapy in phase II clinical trials for use in the treatment of … Read more
Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.031x
Based on the latest financial reports, Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704) has a cash flow conversion efficiency ratio of -0.031x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-19.13 Million) by net assets (NT$625.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Gwo Xi Stem Cell Applied Technology Co. , Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Gwo Xi Stem Cell Applied Technology Co. , Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Gwo Xi Stem Cell Applied Technology Co. , Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Gwo Xi Stem Cell Applied Technology Co. , Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
AirBoss of America Corp
OTCQX:ABSSF
|
0.070x |
|
Peak Minerals Ltd
AU:PUA
|
-1.262x |
|
Spigen Korea Co. Ltd
KQ:192440
|
0.019x |
|
India Nippon Electricals Limited
NSE:INDNIPPON
|
0.001x |
|
Edda Wind ASA
OL:EWIND
|
0.018x |
|
Frasers Property (Thailand) Public Company Limited
BK:FPT
|
0.039x |
|
CuongThuan Idico Development Investment Corp
VN:CTI
|
N/A |
|
Emporiki Eisagogiki Aftokiniton Ditrohon kai Mihanon Thalassis Societe Anonyme
AT:MOTO
|
-0.109x |
Annual Cash Flow Conversion Efficiency for Gwo Xi Stem Cell Applied Technology Co. , Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Gwo Xi Stem Cell Applied Technology Co. , Ltd from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$660.91 Million | NT$-52.28 Million | -0.079x | -1107.92% |
| 2023-12-31 | NT$744.23 Million | NT$-4.87 Million | -0.007x | +94.79% |
| 2022-12-31 | NT$510.32 Million | NT$-64.19 Million | -0.126x | -112.59% |
| 2021-12-31 | NT$492.16 Million | NT$-29.12 Million | -0.059x | +51.22% |
| 2020-12-31 | NT$598.17 Million | NT$-72.56 Million | -0.121x | +13.29% |
| 2019-12-31 | NT$592.65 Million | NT$-82.91 Million | -0.140x | -- |